ARCHIVES

BSA Working Group

This article is from The Cancer Letter archive.

Vol. 36 No. 41 | November 12, 2010

Download PDF Visit The Full Archive

Related Articles

NCI Community Intervention Trial Reports

March 10, 1995

Drug Approved in Europe For Pediatric Cancer Patients

April 24, 2009

Wyden Asks Healy To Clarify CRADA Pricing Clause

January 3, 1992

Patient Advocacy: congress Delivers Symbolism, Not Solution, Visco Says

October 17, 1997

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

June 2, 2006

Correction: Appropriations Reports Included Language of Minorities and Underserved

October 15, 1999